About
Aims
Journal of Nutritional Pharmacology and Bioactive Compounds (JNPBC) aims to advance understanding of how food-derived bioactive compounds modulate molecular signaling, pharmacology, and therapeutic outcomes. The journal publishes rigorous, mechanistic research that links biochemical action with pharmacodynamics, pharmacokinetics, and clinical relevance. It seeks to illuminate how dietary constituents interact with drugs, affect efficacy and safety, and influence disease prevention and management. A key objective is to promote reproducible science by encouraging robust experimental design, transparent reporting, preregistration where appropriate, and data sharing. JNPBC supports interdisciplinary collaboration, bridging biochemistry, pharmacology, toxicology, nutrition science, omics technologies, and clinical research to translate bench findings into actionable health strategies. The journal also aims to foster methodological innovation, including novel analytical approaches, biomarkers of action, and systems-level analyses that reveal network-level effects. By publishing high-quality, open-access work, JNPBC intends to inform clinicians, researchers, policymakers, and industry stakeholders about the role of bioactive compounds in pharmacological contexts and disease risk reduction. The scope emphasizes ethical standards, rigorous peer review, and inclusive access to knowledge that can improve health through evidence-based nutrition and pharmacology.
Scope
• Molecular mechanisms of action for polyphenols, carotenoids, organosulfur compounds, alkaloids, peptides, fatty acids, and microbiota-derived metabolites.
• Pharmacokinetics and pharmacodynamics of dietary bioactives in humans and preclinical models, including dose-response relationships and time courses.
• Interactions between bioactives and conventional pharmacotherapies, drug-metabolizing enzymes, transporters, or transporter-mediated uptake with implications for efficacy and safety.
• Nutrigenomics and nutriepigenomics exploring genomic and epigenetic modulation of signaling networks by bioactives.
• Analytical and omics approaches—bioavailability, metabolomics, proteomics, and biomarker discovery to elucidate mechanisms of action.
• Translational research spanning preclinical models to clinical studies in disease prevention or therapeutic contexts, including cancer, neurodegeneration, metabolic disorders, and inflammation.
• Safety, toxicity, quality control of dietary supplements and nutraceuticals, standardization of preparations, and reproducibility concerns in the literature.
• Formulation science and delivery strategies, including novel dosage forms and nanoencapsulation to optimize bioefficacy and minimize risk.
Article Types
• Original Research Articles
• Review Articles
• Systematic Reviews and Meta-Analyses
• Methods and Protocols
• Brief Reports
• Commentaries and Editorials
Audience
The journal serves researchers and clinicians in pharmacology, nutrition, biomedicine, toxicology, and related fields; policymakers and regulatory scientists; industry professionals in nutraceutical development; educators and students; and interdisciplinary teams seeking mechanistic insights, translational pathways, and evidence-based nutrition strategies to improve health outcomes.